Diagnostic and Biotech

2015-2019 Coagulation Testing in Transition: Convergence of Regulatory Uncertainty, Technological Advances, and Intensifying Competition Create Opportunities with Significant Upside

  • VPG323083
  • 650 Pages
  • August 2015
  • Diagnostic and Biotech
Complete report $24,500. DataPack (test volumes, sales forecasts, supplier shares) $15,900.

2015-2019 Coagulation Testing in Transition: Convergence of Regulatory Uncertainty, Technological Advances, and Intensifying Competition Create Opportunities with Significant Upside is VPGMarketResearchs new seven-country report designed to help current suppliers and potential market entrants identify and evaluate emerging business opportunities and develop effective strategies for the global coagulation testing market during the next five years.


The report explores business and technological trends in the US, Europe (France, Germany, Italy, Spain, UK) and Japan; provides estimates of the test volume, as well as sales and market shares for leading instrument and reagent competitors; compares features of major analyzers; profiles leading market players; analyzes potential applications of emerging technologies; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next five years.


Rationale

The growing cost-containment pressures in major industrialized nations, coupled with continued technological advances in chromogenic substrates, monoclonal antibodies, immunoassays, molecular diagnostics, computers and laboratory automation will radically change the global coagulation diagnostics practice during the next five years. New specific and sensitive markers of coagulation will be increasingly used on automated instrumentation. Coagulation testing will also become more standardized, offering opportunities for quality control products and services. Moreover, the continuing contraction of the hospital system and technological advances will facilitate decentralization of the coagulation testing closer to the patient, thus creating additional opportunities and challenges for suppliers.


Geographic Coverage


France, Germany, Italy, Japan, Spain, UK, USA


Worldwide Market Overview


- Comprehensive market segmentation analysis, including review

of the market dynamics, structure, size, growth and major suppliers

by country.


- Estimated universe of facilities performing coagulation tests

by country.


- Five-year test volume and sales projections by country.


Business Opportunities and Strategic Recommendations


- Product development and business expansion

opportunities with significant market appeal.


- Ideal product models with tentative

prices and operating characteristics.


- Alternative market penetration

strategies for instrument and reagent suppliers.


- Potential market entry barriers and risks.


Current and Emerging Coagulation Tests


Activated Clotting Time (ACT) (1), Activated Protein C Resistance,

Activated PTT (APTT), Alpha 2-Antiplasmin, Antithrombin III, Bleeding Time,

D-Dimer, Factor II, Factor V, Factor V Leiden, Factor VII, Factor VIII, Factor IX,

Factor Ixa, Factor X (Stuart Factor), Factor Xa, Factor XI, Factor XII, Factor XIII,

Fibrin Degradation Products, Fibrinogen, Fletcher Factor/Pre-Kallikrein Factor Activation,

Heparin/Anti-Factor Xa, Heparin-Induced Thrombocytopenia, Plasmin, Plasminogen,

Plasminogen Activator Inhib., Platelet Function/Aggregation, Protein C, Protein S,

Prothrombin Mutation, Prothrombin Time (PT), Reptilase Time, Thrombin Time,

Von Willebrand's Factor Fav/Ag, and others.


Sales and Market Share Analysis of Instrument and Reagent Suppliers


- Sales and market shares of major instrument

and consumable manufactures by country.


Market Segmentation Analysis


- Comprehensive market

segmentation analysis, including:


- Hospitals

- Commercial/Private Laboratories

- Physician Offices

- Ambulatory Care Centers


- Test volume forecasts for over 40 major procedures,

by country and market segment.


Current and Emerging Products


- Review of established and new procedures.


- Comparison of automated and semi-automated

analyzers marketed by Diagnostica Stago, Helena, IL,

Roche, Siemens, Sysmex and other suppliers.


Technology Review


- Analysis of current and emerging technologies

and their potential market applications.


- Comprehensive lists of companies developing

or marketing new technologies and products by test.


Competitive Strategies


- Strategic assessments ofmajor suppliers and start-up firms

developing innovative coagulation testing technologies

and products, including their sales, product portfolios,

marketing tactics, collaborative arrangements, and new products in R&D.


- The companies analyzed in the report include:


- Abbott

- ADI/American Diagnostica

- Axis-Shield

- Alere/Biosite/Inverness

- Beckman Coulter/Danaher

- Becton Dickinson

- Bio/Data

- Chrono-Log

- Corgenix Medical

- Diagnostica Stago/Trinity Biotech

- Grifols

- Helena Laboratories

- Hyphen BioMed

- Instrumentation Laboratory

- ITC/Nexus Dx

- Roche

- Siemens

- Sienco

- Sysmex

- Thermo Fisher

- ZyCare/Alere


Contains 650 pages and 150 tables

Please Select Format

Need More Information

Contact us
+ 1-800-910-6452
+1-971-202-1575
+91 20 66346066
--- or ---
help@bigmarketresearch.com

 

UPCOMING MARKET RESEARCH REPORTS

Global Enteric Disease Testing Market (Therapeutics, Technologies and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2012 - 2020

Enteric disease is a condition caused in the intestine due to the presence of foreign antigen such as bacterial, viral and parasites. The enteric diseases are commonly caused due to ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

World Electrophoresis Market - Opportunities and Forecasts, 2015 - 2020

Electrophoresis is a technique used for separation of proteins and nucleic acids. This technique is primarily used for RNA and DNA analysis. It is also used in biochemistry for separation ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

World Cell Counting Market - Opportunities and Forecasts, 2015 - 2020

Cell counting is a method of counting cells for medical applications, and plays an important role in research and clinical activities. Cell counts in liquid media is expressed in cells ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

World Epigenetics Market - Opportunities and Forecasts, 2015 - 2020

Epigenetics, in the field of genetics, involves study of cellular and physiological trait variations initiated by external or ecological aspects which swipe genes on and off and affect how cells ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global Digital Polymerase Chain Reaction (dPCR) Market (Technology, Type, Application, End User and Geography) - Size, Share, Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2014 - 2020

Digital Polymerase Chain Reaction (dPCR) is an advancement of traditional polymerase chain reaction (PCR). The traditional PCR with its limited precision and accuracy often fail to amplify small samples of ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global Biopharmaceuticals Market (Therapeutics, Products) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020

Biopharmaceuticals are drugs produced from genetically modified source, which are mainly proteins and nucleic acids. According to IMS Health Market Prognosis, the total market size of pharmaceutical industry was approximately ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

2017 © Copyright Big Market Research

View Pricing >>